These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 27109610)

  • 1. Astragaloside IV prevents high glucose-induced podocyte apoptosis via downregulation of TRPC6.
    Yao XM; Liu YJ; Wang YM; Wang H; Zhu BB; Liang YP; Yao WG; Yu H; Wang NS; Zhang XM; Peng W
    Mol Med Rep; 2016 Jun; 13(6):5149-56. PubMed ID: 27109610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NFAT2 mediates high glucose-induced glomerular podocyte apoptosis through increased Bax expression.
    Li R; Zhang L; Shi W; Zhang B; Liang X; Liu S; Wang W
    Exp Cell Res; 2013 Apr; 319(7):992-1000. PubMed ID: 23340267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
    Xing L; Fang J; Zhu B; Wang L; Chen J; Wang Y; Huang J; Wang H; Yao X
    Life Sci; 2021 Mar; 269():119068. PubMed ID: 33476631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astragaloside IV prevents damage to human mesangial cells through the inhibition of the NADPH oxidase/ROS/Akt/NF‑κB pathway under high glucose conditions.
    Sun L; Li W; Li W; Xiong L; Li G; Ma R
    Int J Mol Med; 2014 Jul; 34(1):167-76. PubMed ID: 24718766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus Protects Podocytes from Apoptosis via Downregulation of TRPC6 in Diabetic Nephropathy.
    Ma R; Wang Y; Xu Y; Wang R; Wang X; Yu N; Li M; Zhou Y
    J Diabetes Res; 2021; 2021():8832114. PubMed ID: 34095318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose specifically regulates TRPC6 expression in the podocyte in an AngII-dependent manner.
    Sonneveld R; van der Vlag J; Baltissen MP; Verkaart SA; Wetzels JF; Berden JH; Hoenderop JG; Nijenhuis T
    Am J Pathol; 2014 Jun; 184(6):1715-26. PubMed ID: 24731445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FK506 ameliorates podocyte injury in type 2 diabetic nephropathy by down-regulating TRPC6 and NFAT expression.
    Ma R; Liu L; Jiang W; Yu Y; Song H
    Int J Clin Exp Pathol; 2015; 8(11):14063-74. PubMed ID: 26823720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice.
    Zhang L; Li R; Shi W; Liang X; Liu S; Ye Z; Yu C; Chen Y; Zhang B; Wang W; Lai Y; Ma J; Li Z; Tan X
    Br J Pharmacol; 2013 Sep; 170(2):426-39. PubMed ID: 23826864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astragaloside IV ameliorates diabetic nephropathy in
    Feng H; Zhu X; Tang Y; Fu S; Kong B; Liu X
    Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34278447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of TRPC6 Signal Pathway Alleviates Podocyte Injury Induced by TGF-β1.
    Huang H; You Y; Lin X; Tang C; Gu X; Huang M; Qin Y; Tan J; Huang F
    Cell Physiol Biochem; 2017; 41(1):163-172. PubMed ID: 28214865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase 4 mediates high glucose-induced podocyte apoptosis via upregulation of calcineurin.
    Shi W; Huang Y; Zhao X; Xie Z; Dong W; Li R; Chen Y; Li Z; Wang W; Ye Z; Liu S; Zhang L; Liang X
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1061-1068. PubMed ID: 33019979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.
    Nijenhuis T; Sloan AJ; Hoenderop JG; Flesche J; van Goor H; Kistler AD; Bakker M; Bindels RJ; de Boer RA; Möller CC; Hamming I; Navis G; Wetzels JF; Berden JH; Reiser J; Faul C; van der Vlag J
    Am J Pathol; 2011 Oct; 179(4):1719-32. PubMed ID: 21839714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RANK Deficiency Ameliorates Podocyte Injury by Suppressing Calcium/Calcineurin/ NFATc1 Signaling.
    Liang S; Zhang H; Du Y; Dou C; Liu S; Zhang L; Chen Y; Li R; Ma J; Li Z; Lin T; Zhao X; Zhang Q; Wang W; Ye Z; Liang X; Shi W; Zhang B
    Kidney Blood Press Res; 2018; 43(4):1149-1159. PubMed ID: 30036881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.
    Chen J; Chen Y; Luo Y; Gui D; Huang J; He D
    Eur J Pharmacol; 2014 Aug; 736():86-94. PubMed ID: 24809932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gq signaling causes glomerular injury by activating TRPC6.
    Wang L; Jirka G; Rosenberg PB; Buckley AF; Gomez JA; Fields TA; Winn MP; Spurney RF
    J Clin Invest; 2015 May; 125(5):1913-26. PubMed ID: 25844902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astragaloside suppresses apoptosis of the podocytes in rats with diabetic nephropathy via miR-378/TRAF5 signaling pathway.
    Lei X; Zhang BD; Ren JG; Luo FL
    Life Sci; 2018 Aug; 206():77-83. PubMed ID: 29792879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astragaloside IV/lncRNA-TUG1/TRAF5 signaling pathway participates in podocyte apoptosis of diabetic nephropathy rats.
    Lei X; Zhang L; Li Z; Ren J
    Drug Des Devel Ther; 2018; 12():2785-2793. PubMed ID: 30233141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mTORC2/Akt/NFκB Pathway-Mediated Activation of TRPC6 Participates in Adriamycin-Induced Podocyte Apoptosis.
    Zhang HT; Wang WW; Ren LH; Zhao XX; Wang ZH; Zhuang DL; Bai YN
    Cell Physiol Biochem; 2016; 40(5):1079-1093. PubMed ID: 27960162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress.
    Wang ZS; Xiong F; Xie XH; Chen D; Pan JH; Cheng L
    BMC Nephrol; 2015 Mar; 16():44. PubMed ID: 25886386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt/β-catenin signalling pathway mediates high glucose induced cell injury through activation of TRPC6 in podocytes.
    Li Z; Xu J; Xu P; Liu S; Yang Z
    Cell Prolif; 2013 Feb; 46(1):76-85. PubMed ID: 23294354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.